{"id":2422,"date":"2019-10-06T01:29:23","date_gmt":"2019-10-05T23:29:23","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2422"},"modified":"2024-12-17T10:18:47","modified_gmt":"2024-12-17T09:18:47","slug":"breast-cancer","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/breast-cancer\/","title":{"rendered":"Breast cancer"},"content":{"rendered":"\n<h1>\n\t\tBreast cancer\n\t<\/h1>\n<h3>\n\t\tSummary\n\t<\/h3>\n\t<p>The Breast cancer research group aims to better understand breast cancer development, the origin of disease subtypes, and disease progression and vulnerabilities. The research projects comprise the major disease subtypes as well as BRCA1\/2-mutant breast cancer. The group also works to develop novel targeted preventive approaches and to improve the quality of life of patients. This is a multidisciplinary team that combines the experience and knowledge of clinical and translational researchers.<\/p>\n<h2>320<\/h2>\n<h2>Publications<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2020\/04\/breast_carcinoma_in_a_lymph_node.jpg\" alt=\"breast_carcinoma_in_a_lymph_node\" itemprop=\"image\" height=\"300\" width=\"600\" title=\"breast_carcinoma_in_a_lymph_node\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\">Strategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-0\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t\u2022 HER2-positive breast cancer (S Pern\u00e0s)<br \/>\n\u2022 ER-positive breast cancer (M Gil)<br \/>\n\u2022 Metastatic breast cancer and quality of life (C Falo)<br \/>\n\u2022 Circulating biomarkers (R Villanueva)<br \/>\n\u2022 Genetic basis of breast cancer risk and targeted prevention (MA Pujana)<br \/>\n\u2022 Therapeutic resistance and cancer progression (various PIs)<br \/>\n\u2022 Preclinical development of novel therapies (various PIs)\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\">Selected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-1\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Villacampa,G;Tung,NM;Pernas,S;Par\u00e9,L;Bueno Mui\u00f1o,C;Echavarr\u00eda,I;L\u00f3pez Tarruella,S et al, <strong>Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer<\/strong>, Ann. Oncol., 2023;34(9):doi:10.1016\/j.annonc.2023.05.012<\/li>\n<li>Oliveira,M;Falato,C;Cejalvo,JM;Vila,MM;Tolosa,P;Salvador Bo,FJ;Cruz,J et al, <strong>Patritumab deruxtecan in untreated hormone receptor-positive\/HER2-negative early breast cancer: final results from part A of the window-of- opportunity SOLTI TOT-HER3 pre-operative study<\/strong>, Ann. Oncol., 2023;34(8):670-680, doi:10.1016\/j.annonc.2023.05.004<\/li>\n<li>Patel,PS;Algouneh,A;Krishnan,R;Reynolds,JJ;Nixon,KCJ;Hao,J;Lee,J et al, <strong>Excessive transcription-replication conflicts are a vulnerability of BRCA1-mutant cancers<\/strong>., Nucleic Acids Res., 2023;51(9):4341-4362, doi:10.1093\/nar\/gkad172<\/li>\n<li>Krishnan,R;Lapierre,M;Gautreau,B;Nixon,KCJ;El Ghamrasni,S;Patel,PS;Hao,J et al, <strong>RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells<\/strong>, Nucleic Acids Res., 2023;51(19):10484-10505 doi:10.1093\/nar\/gkad733,<\/li>\n<li>Ciscar,M;Trinidad,EM;Perez Chacon,G;Alsaleem,M;Jimenez,M;Jimenez Santos,MJ;Perez Montoyo,H et al, <strong>RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer<\/strong>., EMBO Mol. Med. 2023;15(4):doi:10.15252\/emmm.202216715<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\">Selected Projects<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-2\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>LCX21020. <strong>Becas de posdoctorado Junior Leader Incoming<\/strong>. FUNDACI\u00d3 &#8220;LA CAIXA&#8221;. Budget: 297.900\u20ac. 2022-2025. PI: GENESTAR PUJANA, MIGUEL ANGEL.<\/li>\n<li>2023-595-1. <strong>A PHASE 3, OPEN-LABEL, RANDOMIZED, TWO-PART STUDY COMPARING GEDATOLISIB IN COMBINATION WITH PALBOCICLIB AND FULVESTRANT TO STANDARD-OF-CARE THERAPIES IN PATIENTS WITH HR-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER PREVIOUSLY TREATED WITH A CDK4\/6 INHIBITOR IN COMBINATION WITH NON-STEROIDAL AROMATASE INHIBITOR THERAPY (VIKTORIA-1)<\/strong>. CELCUITY INC. Budget: 253.918\u20ac. 2023- . PI: Stradella Trucco, Agostina.<\/li>\n<li>2022-061-1. <strong>Ensayo multic\u00e9ntrico, aleatorizado, doble ciego y controlado con placebo, con un periodo de preinclusi\u00f3n con un solo grupo, para evaluar la seguridad y la eficacia de un colirio de tiosulfato de sodio (BYON5667) para reducir la toxicidad ocular en pacientes oncol\u00f3gicos tratados con SYD985.<\/strong> BYONDIS B.V.;Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) . Budget: 221.291\u20ac. 2022- . PI: Stradella Trucco, Agostina.<\/li>\n<li>2021-037-1. <strong>SERENA-4: Ensayo de fase III aleatorizado, multic\u00e9ntrico, doble ciego, de AZD9833 (un SERD, Degradador selectivo del RE, oral) m\u00e1s palbociclib en comparaci\u00f3n con anastrozol m\u00e1s palbociclib para el tratamiento de pacientes con c\u00e1ncer de mama avanzado con receptores estrog\u00e9nicos positivos y HER2 negativo que no han recibido ning\u00fan tratamiento sist\u00e9mico para la enfermedad avanzada.<\/strong> Astrazeneca Farmac\u00e9utica Spain, S.A. Budget: 218.253\u20ac. 2021- . PI: OBADIA GIL, VERONICA LUISA.<\/li>\n<li>FIS22070. <strong>CONTRATOS MIGUEL SERVET<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 202.500\u20ac. 2023-2028. PI: ANTOLIN HERNANDEZ, ALBERT.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\">Technology transfer<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-3\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\tPAT077-&#8220;Dna Damage Repair Deficit In Cancer Cells&#8221;<br \/>\nIP: Miguel Angel Pujana<br \/>\nOWNERSHIP: 25%IDIBELL-ICO, 75% UNIVERSITY OF CALIFORNIA (UCSF)<br \/>\nREQUEST No.: US63\/038,747<br \/>\nPRIORITY COUNTRY: USA<br \/>\nPRIORITY DATE: 12\/06\/2020<br \/>\nPCT APPLICATION: WO2021\/252945 (11\/06\/2021)\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-4\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-4\">More Information<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-4\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<p>The group has extensive experience in bioinformatic and systems biology approaches, combined with in vitro and in vivo experimental studies, aimed at better understanding the development and progression of breast cancer. Over the past five years, the team has published 50 articles on a regular basis, including various manuscripts in leading journals. The team has also received various national and international grants and has established strong collaborations with national and international leaders in the area.<\/p>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/12\/Sonia-Pernas-Simon24-150x150.jpg\" alt=\"Sonia-Pernas-Simon24\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Sonia-Pernas-Simon24\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tPernas Simon, Sonia\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:spernas@idibell.cat\" title=\"spernas@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tspernas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/12\/Ruth-Rodriguez-Barrueco24-150x150.jpg\" alt=\"Ruth-Rodriguez-Barrueco24\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Ruth-Rodriguez-Barrueco24\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tRodriguez Barrueco, Ruth\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:rrodriguezb@idibell.cat\" title=\"rrodriguezb@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\trrodriguezb@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tPrincipal investigators\n\t<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/12\/Sonia-Pernas-Simon24-150x150.jpg\" alt=\"Sonia-Pernas-Simon24\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Sonia-Pernas-Simon24\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tPernas Simon, Sonia\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:spernas@idibell.cat\" title=\"spernas@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tspernas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/12\/Ruth-Rodriguez-Barrueco24-150x150.jpg\" alt=\"Ruth-Rodriguez-Barrueco24\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Ruth-Rodriguez-Barrueco24\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tRodriguez Barrueco, Ruth\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:rrodriguezb@idibell.cat\" title=\"rrodriguezb@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\trrodriguezb@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2021\/06\/Amparo-Garcia-Tejedor-150x150.jpg\" alt=\"Amparo-Garcia-Tejedor\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Amparo-Garcia-Tejedor\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tGarc\u00eda Tejedor, Amparo\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:agarciat@idibell.cat\" title=\"agarciat@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tagarciat@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\tRELATED LINKS\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/ico.gencat.cat\/ca\/recerca\/Programa-ProCURE\/index.html\" title=\"ProCURE\" target=\"_blank\" rel=\"noopener\">\n\t\tProCURE\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/ProcureICO\" title=\"@ProcureICO\" target=\"_blank\" rel=\"noopener\">\n\t\t@ProcureICO\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/SoniaPernas\" title=\"@SoniaPernas\" target=\"_blank\" rel=\"noopener\">\n\t\t@SoniaPernas\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/AmpaGarTej\" title=\"@AmpaGarTej\" target=\"_blank\" rel=\"noopener\">\n\t\t@AmpaGarTej\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/cimba.ccge.medschl.cam.ac.uk\/\" title=\"CIMBA\" target=\"_blank\" rel=\"noopener\">\n\t\tCIMBA\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tTeam\n\t<\/h2>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-0\" data-index=\"0\" aria-selected=\"true\" aria-controls=\"fl-tabs--panel-0\" aria-expanded=\"true\" role=\"tab\" tabindex=\"0\">\t\t\t\tGroup leaders \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-1\" data-index=\"1\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-1\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tPrincipal investigators \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-2\" data-index=\"2\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-2\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tClinical researchers \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-3\" data-index=\"3\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-3\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tPredoctoral researchers\t\t\t\t<\/a>\n\t\t\t\t\t\tGroup leaders \n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Pernas Simon, Sonia<\/li>\n<li>Rodriguez Barrueco, Ruth<\/li>\n<\/ul>\n\t\t\t\t\t\tPrincipal investigators \n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Garc\u00eda Tejedor, Amparo<\/li>\n<\/ul>\n\t\t\t\t\t\tClinical researchers \n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Gil Gil, Juan Miguel<\/li>\n<li>Fernandez Ortega, Adela<\/li>\n<li>Falo Zamora, Catalina<\/li>\n<li>Pla Farn\u00f3s, Mar\u00eda Jes\u00fas<\/li>\n<li>Obadia Gil, Veronica Luisa<\/li>\n<li>Petit Montserrat, Anna<\/li>\n<li>Fullana Grimalt, Bartomeu<\/li>\n<li>Recalde Penabad, Sabela<\/li>\n<li>Stradella Trucco, Agostina<\/li>\n<li>V\u00e1zquez Fern\u00e1ndez, Silvia<\/li>\n<li>Villanueva V\u00e1zquez, Rafael<\/li>\n<\/ul>\n\t\t\t\t\t\tPredoctoral researchers\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Mig\u00f3 Aran J\u00falia<\/li>\n<li>Rodr\u00edguez Barrante, Aintzane<\/li>\n<li>Bonilla Amadeo, Ricard<\/li>\n<\/ul>\n<h2>\n\t\tRelated news\n\t<\/h2>\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24581\" content=\"Advances in chemical biology are fueled by multidisciplinarity and teamwork\" \/><meta itemprop=\"datePublished\" content=\"2024-09-20\" \/><meta itemprop=\"dateModified\" content=\"2024-11-21\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/09\/cover.tif-1.jpg\" \/><meta itemprop=\"width\" content=\"591\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/09\/advances-in-chemical-biology-are-fueled-by-multidisciplinarity-and-teamwork\/\" title=\"Advances in chemical biology are fueled by multidisciplinarity and teamwork\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/09\/advances-in-chemical-biology-are-fueled-by-multidisciplinarity-and-teamwork\/\" title=\"Advances in chemical biology are fueled by multidisciplinarity and teamwork\">Advances in chemical biology are fueled by multidisciplinarity and teamwork<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t20\/09\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24496\" content=\"We all know a mother, that's for her: a solidary wedding raises funds for breast cancer research\" \/><meta itemprop=\"datePublished\" content=\"2024-08-05\" \/><meta itemprop=\"dateModified\" content=\"2024-08-05\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/OL-512_16-9.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/08\/we-all-know-a-mother-thats-for-her-a-solidary-wedding-raises-funds-for-breast-cancer-research\/\" title=\"We all know a mother, that's for her: a solidary wedding raises funds for breast cancer research\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/08\/we-all-know-a-mother-thats-for-her-a-solidary-wedding-raises-funds-for-breast-cancer-research\/\" title=\"We all know a mother, that's for her: a solidary wedding raises funds for breast cancer research\">We all know a mother, that&#8217;s for her: a solidary wedding raises funds for breast cancer research<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t05\/08\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24446\" content=\"A study by IDIBELL and ICO proves the advantages of administering chemotherapy before surgery in stage II and III breast cancer\" \/><meta itemprop=\"datePublished\" content=\"2024-07-16\" \/><meta itemprop=\"dateModified\" content=\"2024-07-16\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/07\/NO075-CFalo.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"767\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/07\/a-study-by-idibell-and-ico-proves-the-advantages-of-administering-chemotherapy-before-surgery-in-stage-ii-and-iii-breast-cancer\/\" title=\"A study by IDIBELL and ICO proves the advantages of administering chemotherapy before surgery in stage II and III breast cancer\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/07\/a-study-by-idibell-and-ico-proves-the-advantages-of-administering-chemotherapy-before-surgery-in-stage-ii-and-iii-breast-cancer\/\" title=\"A study by IDIBELL and ICO proves the advantages of administering chemotherapy before surgery in stage II and III breast cancer\">A study by IDIBELL and ICO proves the advantages of administering chemotherapy before surgery in stage II and III breast cancer<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t16\/07\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24158\" content=\"The VIII Barcelona Fire Brigade Solidarity Nautical Mile 2024 will support research into the rare disease LAM\" \/><meta itemprop=\"datePublished\" content=\"2024-05-28\" \/><meta itemprop=\"dateModified\" content=\"2024-05-28\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/Foto-grup_Pujana_052424-web.jpeg\" \/><meta itemprop=\"width\" content=\"1600\" \/><meta itemprop=\"height\" content=\"900\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/05\/the-viii-barcelona-fire-brigade-solidarity-nautical-mile-2024-will-support-research-into-the-rare-disease-lam\/\" title=\"The VIII Barcelona Fire Brigade Solidarity Nautical Mile 2024 will support research into the rare disease LAM\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/05\/the-viii-barcelona-fire-brigade-solidarity-nautical-mile-2024-will-support-research-into-the-rare-disease-lam\/\" title=\"The VIII Barcelona Fire Brigade Solidarity Nautical Mile 2024 will support research into the rare disease LAM\">The VIII Barcelona Fire Brigade Solidarity Nautical Mile 2024 will support research into the rare disease LAM<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t28\/05\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24032\" content=\"DACMA Association donates 12,000 euros for breast cancer research\" \/><meta itemprop=\"datePublished\" content=\"2024-05-10\" \/><meta itemprop=\"dateModified\" content=\"2024-05-10\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/05\/DACMA2024_web.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/05\/dacma-association-donates-12000-euros-for-breast-cancer-research\/\" title=\"DACMA Association donates 12,000 euros for breast cancer research\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/05\/dacma-association-donates-12000-euros-for-breast-cancer-research\/\" title=\"DACMA Association donates 12,000 euros for breast cancer research\">DACMA Association donates 12,000 euros for breast cancer research<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t10\/05\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/23946\" content=\"Drug repurposing: new opportunities for cancer patients\" \/><meta itemprop=\"datePublished\" content=\"2024-04-19\" \/><meta itemprop=\"dateModified\" content=\"2024-11-21\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/04\/Albert-Antolin-Repurposing.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/04\/drug-repurposing-new-opportunities-for-cancer-patients\/\" title=\"Drug repurposing: new opportunities for cancer patients\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/04\/drug-repurposing-new-opportunities-for-cancer-patients\/\" title=\"Drug repurposing: new opportunities for cancer patients\">Drug repurposing: new opportunities for cancer patients<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t19\/04\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/23602\" content=\"An anticancer drug opens a new path for the treatment of Parkinson&#8217;s\" \/><meta itemprop=\"datePublished\" content=\"2024-02-09\" \/><meta itemprop=\"dateModified\" content=\"2024-11-21\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/02\/Albert-Antolin.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/02\/an-anticancer-drug-opens-a-new-path-for-the-treatment-of-parkinsons\/\" title=\"An anticancer drug opens a new path for the treatment of Parkinson&#8217;s\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/02\/an-anticancer-drug-opens-a-new-path-for-the-treatment-of-parkinsons\/\" title=\"An anticancer drug opens a new path for the treatment of Parkinson&#8217;s\">An anticancer drug opens a new path for the treatment of Parkinson&#8217;s<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t09\/02\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/23610\" content=\"Alterations in the blood immune system found to increase cancer risk\" \/><meta itemprop=\"datePublished\" content=\"2024-02-06\" \/><meta itemprop=\"dateModified\" content=\"2024-02-06\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/02\/Miquel-A\u2560Cngel-Pujana-_0001_2-1-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1280\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/02\/alterations-in-the-blood-immune-system-found-to-increase-cancer-risk\/\" title=\"Alterations in the blood immune system found to increase cancer risk\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2024\/02\/alterations-in-the-blood-immune-system-found-to-increase-cancer-risk\/\" title=\"Alterations in the blood immune system found to increase cancer risk\">Alterations in the blood immune system found to increase cancer risk<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t06\/02\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/23381\" content=\"Scientists open up a new way to fight cancer through the MYC gene\" \/><meta itemprop=\"datePublished\" content=\"2023-12-19\" \/><meta itemprop=\"dateModified\" content=\"2023-12-19\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2023\/12\/NO121-Pujana-Bicara.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2023\/12\/scientists-open-up-a-new-way-to-fight-cancer-through-the-myc-gene\/\" title=\"Scientists open up a new way to fight cancer through the MYC gene\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2023\/12\/scientists-open-up-a-new-way-to-fight-cancer-through-the-myc-gene\/\" title=\"Scientists open up a new way to fight cancer through the MYC gene\">Scientists open up a new way to fight cancer through the MYC gene<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t19\/12\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/23160\" content=\"AELAM donates 15.000\u20ac to research on Lymphangioleiomyomatosis\" \/><meta itemprop=\"datePublished\" content=\"2023-11-03\" \/><meta itemprop=\"dateModified\" content=\"2023-11-03\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2023\/11\/AELAM-2023-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1704\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2023\/11\/aelam-donates-15-000e-to-research-on-lymphangioleiomyomatosis\/\" title=\"AELAM donates 15.000\u20ac to research on Lymphangioleiomyomatosis\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2023\/11\/aelam-donates-15-000e-to-research-on-lymphangioleiomyomatosis\/\" title=\"AELAM donates 15.000\u20ac to research on Lymphangioleiomyomatosis\">AELAM donates 15.000\u20ac to research on Lymphangioleiomyomatosis<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t03\/11\/2023\t\t\t\t\t\t\t\n\t\t<!-- .pp-content-posts -->\n\n","protected":false},"excerpt":{"rendered":"<p>Breast cancer Summary The Breast cancer research group aims to better understand breast cancer development, the origin of disease subtypes, and disease progression and vulnerabilities. The research projects comprise the major disease subtypes as well as BRCA1\/2-mutant breast cancer. The group also works to develop novel targeted preventive approaches and to improve the quality of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2422","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 15:03:15","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=2422"}],"version-history":[{"count":17,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2422\/revisions"}],"predecessor-version":[{"id":24999,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2422\/revisions\/24999"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=2422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}